Your browser doesn't support javascript.
loading
Microtubule-Based Mitochondrial Dynamics as a Valuable Therapeutic Target in Cancer.
Vona, Rosa; Mileo, Anna Maria; Matarrese, Paola.
Afiliación
  • Vona R; Center for Gender-Specific Medicine, Oncology Unit, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Mileo AM; Tumor Immunology and Immunotherapy Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)-Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Matarrese P; Center for Gender-Specific Medicine, Oncology Unit, Istituto Superiore di Sanità, 00161 Rome, Italy.
Cancers (Basel) ; 13(22)2021 Nov 19.
Article en En | MEDLINE | ID: mdl-34830966
Mitochondria constitute an ever-reorganizing dynamic network that plays a key role in several fundamental cellular functions, including the regulation of metabolism, energy production, calcium homeostasis, production of reactive oxygen species, and programmed cell death. Each of these activities can be found to be impaired in cancer cells. It has been reported that mitochondrial dynamics are actively involved in both tumorigenesis and metabolic plasticity, allowing cancer cells to adapt to unfavorable environmental conditions and, thus, contributing to tumor progression. The mitochondrial dynamics include fusion, fragmentation, intracellular trafficking responsible for redistributing the organelle within the cell, biogenesis, and mitophagy. Although the mitochondrial dynamics are driven by the cytoskeleton-particularly by the microtubules and the microtubule-associated motor proteins dynein and kinesin-the molecular mechanisms regulating these complex processes are not yet fully understood. More recently, an exchange of mitochondria between stromal and cancer cells has also been described. The advantage of mitochondrial transfer in tumor cells results in benefits to cell survival, proliferation, and spreading. Therefore, understanding the molecular mechanisms that regulate mitochondrial trafficking can potentially be important for identifying new molecular targets in cancer therapy to interfere specifically with tumor dissemination processes.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia